Overview

Bioequivalency Study of Ensartinib Capsules in Healthy Volunteers

Status:
Completed
Trial end date:
2019-01-09
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the bioequivalency of two preparations of ensartinib capsules in Chinese healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals Co.,Ltd.
Treatments:
Ensartinib